Aeglea BioTherapeutics to Present at BMO Capital Markets … – EconoTimes

[ad_1]

Aeglea BioTherapeutics to Present at BMO Capital Markets Prescription for Success Healthcare Conference

Wednesday, December 7, 2016 1:00 PM UTC

AUSTIN, Texas, Dec. 07, 2016 — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases and cancer, today announced that it will participate on a panel and provide a corporate update at the upcoming BMO Capital Markets Prescription for Success Healthcare Conference on Wednesday, December 14, 2016 in New York.

David G. Lowe, Ph.D., president and chief executive officer of Aeglea, will participate on a panel entitled, “The New Generation of Orphan Companies,” which…

[ad_2]

Read the full article from the Source…

Back to Top